This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Centaurus Biopharma Co., Ltd.. Active years: 2016.
Company Filing History:
Years Active: 2016
Title: The Innovative Contributions of Chonglong Li
Introduction
Chonglong Li is a prominent inventor based in Beijing, China. He has made significant contributions to the field of biopharmaceuticals, particularly in the development of novel compounds for medical applications. His work focuses on creating innovative solutions to combat various diseases.
Latest Patents
Chonglong Li holds a patent for "2,4-diamino-6,7-dihydro-5H-pyrrolo[2,3]pyrimidine derivatives as FAK/Pyk2 inhibitors." This invention relates to a new class of compounds that serve as inhibitors for FAK and/or Pyk2. The patent outlines a process for their preparation, a composition of these compounds, and their use in treating disorders mediated by FAK and/or Pyk2. He has 1 patent to his name.
Career Highlights
Chonglong Li is associated with Centaurus Biopharma Co., Ltd., where he contributes to the advancement of biopharmaceutical research. His expertise in developing inhibitors has positioned him as a key player in the industry. His innovative approach has the potential to lead to significant breakthroughs in treatment methodologies.
Collaborations
Chonglong Li has worked alongside notable colleagues such as Dengming Xiao and Liang Cheng. Their collaborative efforts have further enhanced the research and development initiatives at Centaurus Biopharma Co., Ltd.
Conclusion
Chonglong Li's contributions to the field of biopharmaceuticals exemplify the impact of innovative thinking in medicine. His work on FAK/Pyk2 inhibitors showcases the potential for new treatments that can address complex medical challenges.